National network for patients with Thymic Epithelial Tumors in France
French National Observatory of Patients With Thymic Epithelial Tumor
This study is creating a national network in France to help improve the care and treatment for patients with Thymic Epithelial Tumors by connecting expert centers and organizing discussions about their management.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3262 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Intergroupe Francophone de Cancerologie Thoracique Academic / other |
| Locations | 2 sites (Paris and 1 other locations) |
| Trial ID | NCT02724696 on ClinicalTrials.gov |
What this trial studies
RYTHMIC is a nationwide network established in France to improve the management of patients with Thymic Epithelial Tumors (TET). It focuses on coordinating regional expert centers and facilitating systematic discussions of patient management through national tumor boards. The network aims to enhance patient care by conducting central pathological reviews and monitoring dedicated actions, while also screening patients for future clinical and translational trials.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with Thymic Epithelial Tumors.
Not a fit: Patients with histologies other than Thymic Epithelial Tumors will not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to improved management and outcomes for patients with Thymic Epithelial Tumors.
How similar studies have performed: Other studies have shown success with similar collaborative approaches in cancer management, indicating a promising potential for this network.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient with Thymic Epithelial Tumors Exclusion Criteria: * histology other than Thymic Epithelial Tumors
Where this trial is running
Paris and 1 other locations
- Paris - Institut Curie — Paris, France (Recruiting)
- Villejuif - Institut Gustave Roussy — Villejuif, France (Recruiting)
Study contacts
- Principal investigator: Benjamin BESSE, Dr — Villejuif - Gustave Roussy
- Study coordinator: Franck Morin
- Email: contact@ifct.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.